Cisplatin−Cyclooxygenase Inhibitor Conjugates, Free and Immobilised in Mesoporous Silica SBA-15, Prove Highly Potent against Triple-Negative MDA-MB-468 Breast Cancer Cell Line

For the development of anticancer drugs with higher activity and reduced toxicity, two approaches were combined: preparation of platinum complexes exhibiting higher stability compared to their platinum counterparts and loading them into mesoporous silica SBA-15.